Exploring the Cost and Accessibility of Semaglutide for Patients
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage type 2 diabetes and obesity. By mimicking the GLP-1 hormone, it enhances insulin secretion, slows gastric emptying, and reduces appetite. Clinical trials highlight its efficacy in lowering hemoglobin A1c and its potential cardiovascular benefits.

